Rituximab-induced serum sickness in progressive transformation of germinal centers immunoglobulin G4-related disease: a case report
Serum sickness should be considered as a potential differential diagnosis in patients exhibiting nonspecific systemic symptoms and dermatologic manifestations following exposure to a triggering factor, such as a newly administered monoclonal antibody medication. This is the first known case of rituximab-induced serum sickness in the context of immunoglobulin G4-related disease.
Authors
- Allen Seylani (ORCID: https://orcid.org/0000-0003-4596-2425)
- Alexander Friedman (ORCID: https://orcid.org/0000-0001-5486-6852)
- Sharanya Kumar (ORCID: https://orcid.org/0000-0002-7029-3887)
- Rahul Tuli
- Eric Abedi (ORCID: https://orcid.org/0000-0001-9922-9785)
Institutions
- University of California, Riverside (US)
- Riverside University Health System - Medical Center (US)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1186/s13256-025-05222-1
- Citations
- 2
- Primary Topic
- IgG4-Related and Inflammatory Diseases
- Type
- article
- Field-Weighted Citation Impact
- 3.34